Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Glaxo Wellcome UK Limited, T/A Glaxo Laboratories and/or GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Betnovate Lotion.
| Pharmaceutical Form |
|---|
|
Lotion. |
Betamethasone Valerate 0.122% w/w.
Excipients with known effect: Cetostearyl alcohol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
| List of Excipients |
|---|
|
Methyl Hydroxybenzoate BP |
White High Density Polyethylene (HDPE) GF4750 and Remafin white CEG 020 container with a polyethylene nozzle and a polyethylene cap.
Pack size: 20 ml; 100 ml.
Not all pack sizes may be marketed.
Glaxo Wellcome UK Limited, T/A Glaxo Laboratories and/or GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
PL 10949/0044
Date of first authorisation: 1 February 1993
Date of latest renewal: 26 September 2007
| Drug | Countries | |
|---|---|---|
| BETNOVATE | Albania, Austria, Australia, Brazil, Cyprus, Germany, Estonia, Spain, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
